Future-proof Pharma Labels Market Size (2024 - 2029)

The Future-proof Pharma Labels Market is poised for significant growth, driven by advancements in labeling technology that enhance supply-chain management, cold-chain monitoring, and track-and-trace compliance. The integration of technologies such as RFID and NFC is transforming the pharmaceutical industry by improving the traceability and monitoring of drugs and medical devices from production to consumer delivery. These technologies address critical issues like non-adherence and counterfeiting, which are major concerns for the pharmaceutical sector globally. The demand for NFC-enabled products is increasing due to their ability to enhance patient engagement and provide real-time data, which is crucial for transporting temperature-sensitive pharmaceuticals. Despite the challenges posed by the COVID-19 pandemic, the need for robust labeling systems remains essential for maintaining efficient supply chains in the pharmaceutical industry.

Market Size of Future-proof Pharma Labels Industry

Future-proof Pharma Labels Market  Size
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 14.00 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration High

Major Players

Future-proof Pharma Labels Market Key players

*Disclaimer: Major Players sorted in no particular order

Future-proof Pharma Labels Market Analysis

The Future-proof Pharma Labels Market is expected to register a CAGR of 14% during the forecast period from 2021 to 2026. The future-proof labeling technology is set to transform the pharmaceutical industry during the forecast period, including supply-chain management, cold-chain monitoring, track-and-trace compliance, and authentication. With the usage of technologies such as RFID and NFC, among others, drugs and medical devices are digitally visible, traceable, and well monitored, from the manufacture, all the way through, to retail shelves, and even to the consumer's homes.

Major issues affecting the pharma sectors are the increasing costs associated with non-adherence and counterfeiting, which are expected to be solved by these technologies. Moreover, these issues primarily align with the governments across the globe, that are trying to fight piracy and improve the costly non-adherence. Furthermore, according to the World Health Organization, globally, counterfeiting costs the pharma industry USD 75 billion every year. The integration of these technologies into pharmaceutical labels is currently the most significant opportunity for the vendors as the market is expected to grow much further. Some brands have already begun using RFID technology to authenticate prefilled syringes and track the time and temperature of products during shipping.

  • Moreover, NFC-enabled pharmaceutical products are witnessing higher demand among organizations, primarily owing to their ability to improve patient engagement using a bi-directional communication channel and fostering co-vigilance. The NFC tags used for the solution will provide real-time temperature sensing and data logging across the supply chain essential for the transportation of pharmaceuticals and other temperature-sensitive products that can be adversely affected by conditions in transit. NFC label can carry more data than a barcode or QR code and provide access to a virtually unlimited realm of additional information. Authentication, patient and equipment safety, tamper detection, and educational information are chief benefits, but the potential to personalize consumer interaction is predominantly helpful for pharmaceuticals.
  • Manufacturers in the industry, however, are on the lookout for a more reliable way other than RFID for the process of manufacturing control in the pharmaceutical industry, as well as for product tracking & tracing of drug quality. This has led to the initiation of the next phase of adoption of Smart technologies, driven by the latest technologies, such as the Internet of Things (IoT) and the near-field communication (NFC) technology that is emerging as an incredible array of essential operations in the industry. In August 2019, WISeKey International Holding Ltd, a cybersecurity IoT platform company, announced the launch of its patented anti-counterfeiting NFC device that is designed to protect the pharmaceutical industry from the escalating counterfeit problem.
  • Although the pharma industry has been fighting against COVID-19 with drugs and vaccines, the pharmaceutical industry's work has also been affected by the pandemic, primarily through the disruption of supply chains. A survey by Pharmaceutical Technology on the pharma supply chain to maintain adequate supplies of medicines amid the COVID-19 pandemic resulted in a relatively even split in opinion, with 24% of respondents stating they are incredibly confident medicine supplies won't be disrupted, while 22% were extremely doubtful. This difference of opinion continues in the less extreme answers, with 23% of voters being somewhat confident, and 20% being somewhat questionable. This drives the need for robust and future-proof labeling systems for the efficient functioning of the pharma supply chain.

Future-proof Pharma Labels Industry Segmentation

Pharmaceutical companies across the globe need solutions that could reverse the cost associated with the issues of counterfeiting and non-adherence. Future-proofing label technologies provide the solutions that can be used by the organizations for redirecting losses into investments in packaging, and potentially into profits. Technologies like RFID, NFC, among others, are being used to mitigate these issues.

Technology
RFID
NFC
Sensing Labels
Other Technologies
Geography
North America
United States
Canada
Europe
United Kingdom
Germany
France
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East and Africa
Need A Different Region Or Segment?
Customize Now

Future-proof Pharma Labels Market Size Summary

The Future-proof Pharma Labels Market is poised for significant transformation, driven by the integration of advanced technologies such as RFID and NFC. These technologies are revolutionizing various aspects of the pharmaceutical industry, including supply-chain management, cold-chain monitoring, and track-and-trace compliance. The adoption of these technologies addresses critical challenges such as counterfeiting and non-adherence, which are major concerns for the industry globally. The market is witnessing increased demand for NFC-enabled products due to their ability to enhance patient engagement and provide real-time data across the supply chain. This shift towards smart labeling solutions is seen as a substantial opportunity for vendors, as it promises to improve the safety, security, and efficiency of pharmaceutical operations.

The market landscape is moderately competitive, with key players like CCL Industries Inc., Avery Dennison Corporation, and NiceLabel leading the charge through product innovations and strategic partnerships. These companies are focusing on expanding their geographic reach and enhancing their product offerings to maintain a competitive edge. The market's growth is further supported by the rising need for anti-counterfeiting measures, particularly in regions like Asia, where counterfeit drugs are prevalent. The ongoing developments in RFID and NFC technologies, coupled with the increasing demand for personalized medicine, are expected to drive the market forward, offering robust solutions for the complex challenges faced by the pharmaceutical industry.

Explore More

Future-proof Pharma Labels Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Increasing Counterfeiting Cases

      2. 1.2.2 Mitigation of Non-adherence

    3. 1.3 Market Restraints

      1. 1.3.1 Lack of Standards and Additional Cost

    4. 1.4 Industry Value Chain Analysis

    5. 1.5 Industry Attractiveness - Porter's Five Forces Analysis

      1. 1.5.1 Threat of New Entrants

      2. 1.5.2 Bargaining Power of Buyers/Consumers

      3. 1.5.3 Bargaining Power of Suppliers

      4. 1.5.4 Threat of Substitute Products

      5. 1.5.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Technology

      1. 2.1.1 RFID

      2. 2.1.2 NFC

      3. 2.1.3 Sensing Labels

      4. 2.1.4 Other Technologies

    2. 2.2 Geography

      1. 2.2.1 North America

        1. 2.2.1.1 United States

        2. 2.2.1.2 Canada

      2. 2.2.2 Europe

        1. 2.2.2.1 United Kingdom

        2. 2.2.2.2 Germany

        3. 2.2.2.3 France

        4. 2.2.2.4 Rest of Europe

      3. 2.2.3 Asia-Pacific

        1. 2.2.3.1 China

        2. 2.2.3.2 India

        3. 2.2.3.3 Japan

        4. 2.2.3.4 South Korea

        5. 2.2.3.5 Rest of Asia-Pacific

      4. 2.2.4 Rest of the World

        1. 2.2.4.1 Latin America

        2. 2.2.4.2 Middle East and Africa

Future-proof Pharma Labels Market Size FAQs

The Future-proof Pharma Labels Market is projected to register a CAGR of 14% during the forecast period (2024-2029)

CCL Industries, Avery Dennison Corporation, UPM Raflatac, Inc., Schreiner Group and NiceLabel (Euro Plus d.o.o.) are the major companies operating in the Future-proof Pharma Labels Market.

Future-proof Pharma Labels Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)